Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen
- PMID: 34143442
- DOI: 10.1002/bit.27864
Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen
Abstract
Yellow fever (YF) is a life-threatening viral disease endemic in parts of Africa and Latin America. Although there is a very efficacious vaccine since the 1930s, YF still causes 29,000-60,000 annual deaths. During recent YF outbreaks there were issues of vaccine shortage of the current egg-derived vaccine; rare but fatal vaccine adverse effects occurred; and cases were imported to Asia, where the circulating mosquito vector could potentially start local transmission. Here we investigated the production of YF virus-like particles (VLPs) using stably transfected HEK293 cells. Process intensification was achieved by combining sequential FACS (fluorescence-activated cell sorting) rounds to enrich the stable cell pool in terms of high producers and the use of perfusion processes. At shaken-tube scale, FACS enrichment of cells allowed doubling VLP production, and pseudoperfusion cultivation (with daily medium exchange) further increased VLP production by 9.3-fold as compared to batch operation mode. At perfusion bioreactor scale, the use of an inclined settler as cell retention device showed operational advantages over an ATF system. A one-step steric exclusion chromatography purification allowed significant removal of impurities and is a promising technique for future integration of upstream and downstream operations. Characterization by different techniques confirmed the identity and 3D-structure of the purified VLPs.
Keywords: FACS for high producers; HEK293 cells; perfusion cultivation; stable expression; virus-like particles (VLPs); yellow fever virus.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Alvim, R. G. F. , Itabaiana, I., Jr. , & Castilho, L. R. (2019). Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform. Vaccine, 37, 6970-6977. https://doi.org/10.1016/j.vaccine.2019.05.064
-
- Bielser, J. M. , Wolf, M. , Souquet, J. , Broly, H. , & Morbidelli, M. (2018). Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review. Biotechnology Advances, 36, 1628-1640. https://doi.org/10.1016/j.biotechadv.2018.04.011
-
- Carvalho, R. J. , Castilho , & L. R. (2017). Tools enabling continuous and integrated upstream and downstream processes in the manufacturing of biologicals, Continuous Biomanufacturing: Innovative Technologies and Methods (pp. 31-61). Wiley-VCH Verlag GmbH & Co. KGaA.
-
- Castilho , & L. R. (2015). Continuous animal cell perfusion processes: The first step toward integrated continuous biomanufacturing, Continuous Processing in Pharmaceutical Manufacturing (pp. 115-154. Wiley Blackwell. https://doi.org/10.1002/9783527673681.ch06
-
- Centers for Disease Control and Prevention. (2019). Yellow fever. https://www.cdc.gov/yellowfever/index.html
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources